Northern Light Venture Capital

Northern Light Venture Capital (北极光创投) is an early-stage venture capital firm active in China's tech investment scene. The fund appears in elsewhere's corpus primarily through its co-investment activity alongside other established firms. It participated in a 2017 early-stage enterprise compensation survey alongside 5Y Capital, ZhenFund, and others , and has backed companies including rural mobility platform Shima (co-leading its Series B with 5Y Capital) , memory-converged infrastructure company MemVerge (in both its 2019 Series A and 2020 strategic round) , and biotech firm Hangzhou Andao Pharma (co-leading its $50 million Series B with Gaorong Ventures in late 2021) . It also joined the Series A of chip design startup Shima Microelectronics in 2022 . The firm's investment footprint spans enterprise software, semiconductor, and healthcare sectors, typically entering at Series A or B stage in syndicated rounds.